Editas shares boosted as patent office rules in favor of Broad’s CRISPR patents

TOPICS:Fashion
Editas shares boosted as patent office rules in favor of Broad’s CRISPR patents

Posted By: Advance February 28, 2022

The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute of MIT and Harvard in a dispute over the patents around CRISPR gene editing technology. | The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute in a dispute over the patents around CRISPR gene editing technology, sending Editas’ shares up.